Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • C vs GSK✓SelectedUSD · GSKC vs GSK performance historyLatest closeAs of-0.04%11/13
Stock and ETF performance explorer

C vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+113.6%
GSK return
+44.4%
Excess return
+69.2%
Maximum drawdown
-40.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%+0.5%-0.6%-0.1%
7D+4.2%+1.1%+3.0%+4.0%
30D+2.0%+6.3%-4.4%+0.8%
3M-10.1%+1.8%-11.9%-10.5%
6M+1.0%+1.7%-0.7%+0.4%
YTD+8.5%+6.5%+1.9%+6.8%
1Y+25.7%+9.5%+16.2%+23.1%
3Y+216.0%+65.3%+150.7%+173.5%
All+113.6%+44.4%+69.2%+88.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling